Core Viewpoint - The article highlights the innovative journey of Wang Shengxue, founder of Suzhou Yingchuang Medical Technology Co., Ltd., who aims to revolutionize medical imaging safety through the development of self-blood contrast agents, addressing long-standing safety concerns in traditional contrast agents [5][6][12]. Group 1: Entrepreneurial Journey - Wang Shengxue transitioned from investment banking to entrepreneurship, driven by a desire to solve clinical pain points in the field of medical imaging [8][10]. - The company was founded in September 2024, focusing on cutting-edge technology in the medical sector [10]. Group 2: Technological Innovation - The self-blood NOCA technology represents a significant advancement in medical imaging, utilizing the patient's own blood to enhance MRI scans, thus eliminating the risks associated with traditional metal-based contrast agents [12]. - This innovative approach has completed large animal experiments and is moving towards human trials, positioning the company at the forefront of global medical technology [12]. Group 3: Management Philosophy - As a non-technical CEO, Wang Shengxue emphasizes a management philosophy based on trust in the project and the team's expertise, ensuring that professionals handle their respective areas [14]. - Participation in the "Pudong Science and Technology - Haiwang Summit CEO Training Camp" has further refined her management approach, allowing her to understand the operational models of other high-tech industries [16][18]. Group 4: Industry Insights - The training camp provided insights into various hard technology sectors, enabling Wang to learn from the successes and challenges faced by entrepreneurs in different fields, which can be applied to the medical industry [18]. - The curriculum of the training camp was designed to offer practical knowledge and real-world case studies, helping early-stage entrepreneurs avoid common pitfalls [18].